Literature DB >> 26376356

Why and how have drug discovery strategies in pharma changed? What are the new mindsets?

Serge Mignani1, Scot Huber2, Helena Tomás3, João Rodrigues4, Jean-Pierre Majoral5.   

Abstract

In the pharmaceutical industry the long-term challenge of drug innovation is the key phrase throughout R&D that refers to increasing the output of original drug candidate molecules. To increase R&D productivity, implementation of new and strategic R&D orientations to develop new approaches or systems to identify hits and leads efficiently has taken place and enabled all scientists working in the drug discovery domain to develop innovative medicines for the 21st century.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26376356     DOI: 10.1016/j.drudis.2015.09.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  16 in total

1.  Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Authors:  Arzu Selen; Anette Müllertz; Filippos Kesisoglou; Rodney J Y Ho; Jack A Cook; Paul A Dickinson; Talia Flanagan
Journal:  AAPS J       Date:  2020-07-27       Impact factor: 4.009

2.  From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds.

Authors:  Giosuè Costa; Anna Artese; Francesco Ortuso; Stefano Alcaro
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery.

Authors:  Maykel Cruz-Monteagudo; Stephan Schürer; Eduardo Tejera; Yunierkis Pérez-Castillo; José L Medina-Franco; Aminael Sánchez-Rodríguez; Fernanda Borges
Journal:  Drug Discov Today       Date:  2017-03-06       Impact factor: 7.851

Review 4.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

5.  Sub-lethal effects induced by a mixture of different pharmaceutical drugs in predicted environmentally relevant concentrations on Lithobates catesbeianus (Shaw, 1802) (Anura, ranidae) tadpoles.

Authors:  Diogo Ferreira do Amaral; Mateus Flores Montalvão; Bruna de Oliveira Mendes; Amanda Pereira da Costa Araújo; Aline Sueli de Lima Rodrigues; Guilherme Malafaia
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-08       Impact factor: 4.223

Review 6.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

7.  Co-Immobilized Capillary Enzyme Reactor Based on Beta-Secretase1 and Acetylcholinesterase: A Model for Dual-Ligand Screening.

Authors:  Adriana Ferreira Lopes Vilela; Vitor Eduardo Narciso Dos Reis; Carmen Lúcia Cardoso
Journal:  Front Chem       Date:  2021-07-08       Impact factor: 5.221

8.  Use of big data in drug development for precision medicine: an update.

Authors:  Tongqi Qian; Shijia Zhu; Yujin Hoshida
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-05-20

Review 9.  Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.

Authors:  Senthilkumar Kalimuthu; Ju Hye Jeong; Ji Min Oh; Byeong-Cheol Ahn
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

Review 10.  Managing risks in drug discovery: reproducibility of published findings.

Authors:  Aimo Kannt; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-17       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.